BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6287718)

  • 1. Epstein-Barr virus induction by a serum factor. I. Induction and cooperation with additional inducers.
    Bauer G; Höfler P; Zur Hausen H
    Virology; 1982 Aug; 121(1):184-94. PubMed ID: 6287718
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
    Yanase S; Sugawara K
    Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis.
    Bauer G
    J Gen Virol; 1983 Jun; 64 (Pt 6)():1337-46. PubMed ID: 6304236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibition of DNA synthesis on Epstein--Barr virus induction by tumor promoters.
    Yamamoto N; zur Hausen H
    Virology; 1980 Feb; 101(1):104-10. PubMed ID: 6243817
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of activated serum factor on the induction of Epstein-Barr virus antigens and cell differentiation.
    Roubalová K; Anisimová E; Roubal J
    Arch Virol; 1985; 85(1-2):85-94. PubMed ID: 2990391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the expression of Fc receptor produced by induction of Epstein-Barr virus in lymphoma cell lines.
    Yee C; Costa J; Hamilton V; Klein G; Rabson AS
    Virology; 1982 Jul; 120(2):376-82. PubMed ID: 6285610
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemically purified serum factor can induce both Epstein-Barr virus antigen synthesis and cell differentiation.
    Anisimová E; Roubalová K; Bauer G; Roubal J
    Arch Virol; 1987; 94(3-4):309-14. PubMed ID: 3034214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids.
    Klein G; Vilcek J
    J Gen Virol; 1980 Jan; 46(1):111-7. PubMed ID: 6243338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibitory effects of retinoic acid on Epstein-Barr virus induction in producer and nonproducer cell lines.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1984; 22(1):56-60. PubMed ID: 6329997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of efficiency of various methods of induction of Epstein-Barr virus antigens synthesis in human lymphoblastoid cell lines].
    Prachová K
    Cesk Epidemiol Mikrobiol Imunol; 1982 Jul; 31(4):236-41. PubMed ID: 6288272
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Umeda R; Ogura H; Hatano M
    Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid inhibition of Epstein-Barr virus induction.
    Yamamoto N; Bister K; zur Hausen H
    Nature; 1979 Apr; 278(5704):553-4. PubMed ID: 219367
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate.
    Roubal J; Luka J; Klein G
    Cancer Lett; 1980 Jan; 8(3):209-12. PubMed ID: 6261939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of arabinofuranosylthymine on Epstein-Barr virus replication.
    Ooka T; Calender A
    Virology; 1980 Jul; 104(1):219-23. PubMed ID: 6249024
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.
    Derge JG; Martos LM; Tagamets MA; Chang SY; Chakrabarty M
    Nat New Biol; 1973 Aug; 244(137):214-7. PubMed ID: 4353682
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of protease inhibitors on the activation of Epstein-Barr virus repressed in cultured lymphoid cells.
    Morigaki T; Sugawara K; Ito Y
    Intervirology; 1981; 16(1):49-52. PubMed ID: 6276326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential inhibition of Epstein-Barr virus induction by the amino acid analogue, L-canavanine.
    Yamamoto N; Mueller-Lantzsch N; zur Hausen H
    Int J Cancer; 1980 Apr; 25(4):439-43. PubMed ID: 6246007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
    Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
    Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.